Background image for the top navigation. The Barbara Bush Children's Hospital link. Clinicians page link. Works on Wellness and Employee Benefits page link Family Services page link. Link to Senior Services page.
Email to a friend    Printer Friendly Page
Text Size: decrease font increase font

Nephrology Fellowship

 John P. Vella, MD, FACP, FRCP, FASN 


Maine Transplant Program

  Medical School: Royal College of Surgeons
Dublin, Ireland
  Internal Medicine Residency: Beaumont Hospital
Dublin, Ireland
  Nephrology Fellowship:

Beaumont Hospital
Dublin, Ireland

  Research Fellowship: Transplant immunobiology and clinical transplantation
Brigham & Women’s Hospital
Boston, Massachusetts
  Academic Appointments: Associate Professor of Medicine
Tufts University School of Medicine
Boston, MA
  Administrative Appointments Director
Maine Transplant Program
Maine Medical Center
Portland, Maine
  Areas of Clinical Interest:

Renal transplantation
Diagnostic renal ultrasonography

Selected Publications:   

Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J : Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79:914-919, 2005

Bostom AG et al, for the FAVORIT Investigators. Rationale and design of the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial. Am Heart J 2006; 152:448

Womer K, Magee C, Najafian N, Vella JP, Milford EM, Sayegh MH, Carpenter CB. A Pilot Study On The Immunological Effects Of Oral Donor Mhc Class Ii Peptides In Renal Transplant Recipients. Transplantation. Clin Transplant 2008 22(6):754-759  

Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella JP, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following kidney transplantation. PNAS 2009 106(9): 3390-3395 

McPhee L, Stogsdill P, Vella JP, Nocardia farcinica pericarditis after kidney transplantation despite prophylaxis. Transplant Infectious Disease 2009 11(5):448-453

Schroppel B, Kruger B, Walsh L, Yeung M, Harris S, Garrison K, Himmelfarb J, Lerner SM, bromberg JS, Zhang PL, Bonventre JV, Wang Z, Farris AB, Colvin RB, Murphy BT, Vella JP. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 2010 21(3):536-542

Yablon Z, Recupero P, McKenna J, Vella J, Parker MG. Kidney allograft biopsy: Timing to complications. Clinical Nephrology 2010 74(1):39-45

Mangray M, Vella JP. Hypertension after Kidney Transplant. Am J Kidney Dis 2011 57(2): 331-341

Hoch D, Vella JP: Obesity and Kidney Transplantation. Am J Transplant, 2012, in press

Andrew G. Bostom, Myra A. Carpenter, John W. Kusek, Andrew S. Levey, Lawrence Hunsicker, Marc A. Pfeffer, Jacob Selhub, Paul F. Jacques, Edward Cole, Lisa Gravens-Mueller, Andrew A. House, Clifton Kew, Joyce L. McKenney, Alvaro Pacheco-Silva, Todd Pesavento, John Pirsch, Stephen Smith, Scott Solomon et al.  Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial Circulation Apr 11, 2011


Vella JP Approach to Medical Complications after Kidney Transplantation. Core Concepts in Renal Transplantation, 

Singh, Sayegh, and Chandraker, eds. 2012

Learn more about the MaineHealth family.
Interested in volunteering?
Health Information

Maine Medical Center | 22 Bramhall Street | Portland, Maine 04102-3175 | (207) 662-0111